430 E. 29th street
About Prevail Therapeutics
Prevail Therapeutics is a biotechnology company focused on developing novel biologic therapies for Parkinson’s Disease and other neurodegenerative diseases. Prevail was launched in 2017 by The Silverstein Foundation for Parkinson’s with GBA, REGENXBIO, and OrbiMed, and is headquartered in New York, NY.
Founders: Silverstein Foundation for Parkinson’s with GBA, REGENXBIO, OrbiMed, and Asa Abeliovich
1 job with Prevail Therapeutics
Play an important role in every aspect of Prevail’s scientific mission, from target discovery to pre-clinical and clinical phases.